Department of Biochemistry Jang, Tae-ho, College of Pharmacy Kim, Tae-hyeong
Published several theses as main author in SCI level journals during the two years in masters' degree course
[February 14, 2011]
On the 22nd, world-acclaimed scholars will receive their masters' degrees after publishing several theses as the main authors in international SCI level journals during their two years in masters' degree courses.
World-acclaimed scholars (from left, Jang, Tae-ho, Kim, Tae-hyeong)
They are Jang, Tae-ho (27) who is in the graduate school of Biochemistry and Kim, Tae-hyeong (27) in the graduate school of Pharmacy. They both enrolled in the Yeungnam University graduate school master's degree course in March 2009 and will receive their master's degree after accomplishing outstanding research achievements after two years.
Jang, who majors in Biochemistry and is planning to enroll in the PhD program, worked on understanding the molecular-level union of proteins that play a part in the transmission of cell signals for the past two years, and by making chemicals or peptides that retard or promote such union, he worked on developing medicine to treat various diseases caused by the failure of cell signal transmission. In the process, he published a total of six papers in prominent SCI level international journals in the biochemical and molecular biology sectors such as ≪Journal of Biotechnology≫, ≪Apoptosis≫, ≪Biochim Biophys Acta≫, placing five of his papers as the main author.
His adviser, Professor Park, Hyun-ho (36, School of Biotechnology), stated, "It is a very rare case where one person publishes five papers in globally recognized SCI level journals during the two-year course of a master's degree program," adding, "He not only has a sharp mind as a student of science, but also has a diligent attitude so I trust that he will grow into an excellent scientist."
Kim, Tae-hyeong, who is in the graduate school of Pharmacy, will also be receiving his master's degree on this day, and he placed his name as the main author on the 28th of last month for the SCI-level international journal ≪Cancer Research≫ online edition. ≪Cancer Research≫, which has an impact factor of 7.5, is one of the most prominent academic journals in the cancer research sector, and it is very rare for a student in their master's degree course to have his paper publish in this journal.
The title of his thesis was ‘Nrf2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α'. He revealed the functions of 'Nrf2' as a new target molecule that suppresses generation of new blood vessels through HIF-1α in the colon tumor model. ‘Nrf2’ is an important transcription factor that induces the revealing of Anti-Oxidant genes.
This research was made through the support of the support program for leading researchers of the National Research Foundation of Korea and the Phase 2 BK21 Project (BK21 Human Resources Development for Development and Effect-Evaluation of Improved New Medicine) under the supervision of Professor Kwak, Mi-Kyoung (College of Pharmacy, Pharmacological Research Office). Kim has already earned a job as a researcher at Dong-A Pharmaceutical, and is working hard on researching and developing new medicine.
Meanwhile, Yeungnam University will hold a commencement ceremony for the 2010 school year at the Chunma Art Center Chamber Hall at 11am on the 22nd and give diplomas to 73 PhDs, 502 masters and 4,108 bachelors. Also, 491 undergraduates who majored in two or more majors will receive multiple diplomas.
